JRQ-31426-30144
3 vaccinations
2 coded responses
11 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 992 / WA
- Registered
- 2021-08-29
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-24
Dose 1 — Pfizer-BioNTech
-
2021-08-29
Registered in v-safe
- 2021-08-29
- 2021-09-02
- 2021-09-09
-
2021-09-14
Dose 2 — Pfizer-BioNTech
- 2021-09-23
- 2021-09-30
- 2021-10-07
- 2021-10-13
- 2021-10-19
- 2021-10-28
-
2022-03-11
Dose 3 — Pfizer-BioNTech
-
2022-09-14
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Positive with Covid-19MedDRA releases: 2024-11 · check-in free text available
-
2022-09-14
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Positive with COVID-19MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-24 | Pfizer-BioNTech | No |
| 2 | 2021-09-14 | Pfizer-BioNTech | No |
| 3 | 2022-03-11 | Pfizer-BioNTech | No |
Free text
Release 12 — 6 months, dose 3
Symptoms: Positive with Covid-19
Release 12 — 12 months, dose 2
Symptoms: Positive with COVID-19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release